Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

44 results
Display

Personalized treatment of hepatitis B

Lok AS

There are seven approved drugs for treatment of hepatitis B. Professional guidelines provide a framework for managing patients but these guidelines should be interpreted in the context of the individual...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prevention of Hepatitis B reactivation in the setting of immunosuppression

Pattullo V

Advances in the treatment of malignant and inflammatory diseases have developed over time, with increasing use of chemotherapeutic and immunosuppressive agents of a range of drug classes with varying mechanism...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Multicentric Hepatocellular Carcinomas and Multiple Dysplastic Nodules: Spectrum of Nodular Lesions in Hepatitis B-viral Cirrhotic Liver

Seok JY, Kim SK, Park YN

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prevention of liver cancer: basic and clinical aspects

Moriwaki H

  • KMID: 755202
  • Exp Mol Med.
  • 2002 Nov;34(5):319-325.
Cancer prevention is a challenging project both in the basic and clinical medicine. In particular, prevention of liver cancer is the most urgent task in countries where the incidence of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Differences in the patterns and outcomes of enhanced viral replication between hepatitis C virus and hepatitis B virus in patients with hepatocellular carcinoma during transarterial chemolipiodolization

Sung PS, Bae SH, Jang JW, Song DS, Kim HY, Yoo SH, Park CH, Kwon JH, Song MJ, You CR, Choi JY, Yoon SK

BACKGROUND/AIMS: Enhanced replication of hepatitis C virus (HCV) is well described in the setting of moderate to severe immunosuppression. The aims of this retrospective study were to determine the incidence...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Changes of guidelines diagnosing hepatocellular carcinoma during the last ten-year period

Song DS, Bae SH

Hepatocellular carcinoma (HCC) is the third most common cause of cancer deaths in the world. There have been many advances in the diagnosis of HCC during the last ten years,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Risk of Pancreatic Cancer in Relation to ABO Blood Group and Hepatitis C Virus Infection in Korea: A Case-Control Study

Woo SM, Joo J, Lee WJ, Park SJ, Han SS, Kim TH, Koh YH, Kim HB, Hong EK

Several studies have reported that ABO blood group, hepatitis B virus (HBV) and hepatitis C virus (HCV) infection contribute to the development of pancreatic cancer. The aim of this study...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Shifting Prevalence of Gallbladder Polyps in Korea

Lee YJ, Park KS, Cho KB, Kim ES, Jang BK, Chung WJ, Hwang JS

Only a few studies have evaluated the population-adjusted prevalence of gallbladder polyps (GBP). This study aimed to evaluate the changes in GBP prevalence and risk factors at a single health...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prevalence of Occult Hepatitis B Virus Infection in Hemodialysis Patients

Yoo JH, Hwang SG, Yang DH, Son MS, Kwon CI, Ko KH, Hong SP, Park PW, Rim KS

BACKGROUND/AIMS: The prevalence of occult HBV infection depends on the prevalence of HBV infection in the general population. Hemodialysis patients are at increased risk for HBV infection. The aim of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Prophylactic Use of Lamivudine Can Maintain Dose-Intensity of Adriamycin in Hepatitis-B Surface Antigen (HBs Ag)-positive Patients with Non-Hodgkin's Lymphoma Who Receive Cytotoxic Chemotherapy

Lee GW, Ryu MH, Lee JL, Oh S, Kim E, Lee JH, Kim SB, Kim SW, Suh C, Lee KH, Kim WK, Lee JS, Kang YK

We investigated the effectiveness of lamivudine to prevent hepatitis flare up due to reactivation of hepatitis-B virus (HBV) in hepatitis-B surface antigen (HBsAg)-positive patients with Non-Hodgkin's lymphoma (NHL) during cytotoxic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Fibrosing cholestatic hepatitis: a report of three cases

Lee HK, Yoon GS, Min KS, Jung YW, Lee YS, Suh DJ, Yu E

Fibrosing cholestatic hepatitis is an aggressive and usually fatal form of viral hepatitis in immunosuppressed patients. We report three cases of fibrosing cholestatic hepatitis in various clinical situations. Case 1...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hepatocellular Carcinoma in the Elderly: Clinical Characteristics, Treatment, Survival Analysis in Korean Patients Older than 70 Years

Kim YJ, Jang BK, Kim ES, Chung WJ, Park KS, Cho KB, Hwang JS

The prevalence of hepatocellular carcinoma (HCC) has increased in recent years. However, HCC remains poorly characterized in elderly patients, and comprehensive data are limited. This study aimed to investigate the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Five-Year Review of HIV-Hepatitis B Virus (HBV) Co-Infected Patients in a New York City AIDS Center

Kim JH, Psevdos G, Sharp V

A retrospective review of 4,721 human immunodeficiency virus (HIV)-infected patients, followed at St. Luke's Roosevelt Hospital Center, New York City, was conducted from January 1, 2005 to December 31, 2009....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prevalence and Clinical Significance of Diabetes Mellitus in Patients with Liver Cirrhosis

Kwon SY

  • KMID: 863156
  • Korean J Hepatol.
  • 2003 Sep;9(3):205-211.
BACKGROUND/AIMS: Impaired glucose tolerance and overt diabetes mellitus (DM) frequently occurs in patients with chronic liver disease. Hyperinsulinaemia and peripheral insulin resistance contribute to the development of DM in these...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Estimated Prevalence and Risk Factor for Age-related Maculopathy

Roh MI, Kim JH, Byeon SH, Koh HJ, Lee SC, Kwon OW

PURPOSE: To assess the estimate prevalence and risk factors for age-related maculopathy (ARM) in Seoul, Korea. PATIENTS AND METHODS: We examined 9,530 subjects with, 40 years of age or older...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Association of common promoter polymorphisms of MCP1 with hepatitis B virus clearance

Park BL, Kim YJ, Cheong HS, Kim LH, Choi YH, Lee HS, Shin HD

  • KMID: 1115948
  • Exp Mol Med.
  • 2006 Dec;38(6):694-702.
Hepatocellular carcinoma (HCC) is one of the most common malignant cancers closely associated with chronic infection by the hepatitis B virus (HBV) or the hepatitis C virus (HCV) throughout the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Is the Prevalence of Cryptogenic Hepatocellular Carcinoma Increasing in Korea?

Oh KC, Park SH, Park JC, Jin DK, Park CS, Kim KO, Jang HJ, Lee JY, Park CH, Han TH, Yoo KS, Kim JH, Kim DJ, Lee MS, Park CK

  • KMID: 772716
  • Korean J Gastroenterol.
  • 2005 Jan;45(1):45-51.
BACKGROUND/AIMS: Nonalcoholic fatty liver disease (NAFLD) has been characterized by a wide spectrum of liver damages that span from steatosis to cryptogenic liver cirrhosis and even to hepatocellular carcinoma...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease

Kwak MS, Kim D, Chung GE, Kang SJ, Park MJ, Kim YJ, Yoon JH, Lee HS

BACKGROUND/AIMS: Serum bilirubin exerts antioxidant and cytoprotective effects. In addition, elevated serum bilirubin levels are associated with a decreased risk of metabolic and cardiovascular diseases. However, few studies have evaluated...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Association of Interleukin-12 Gene Polymorphism with Persistence of Hepatitis B Virus Infection and Hepatocellular Carcinoma

Park JS, Cheong JY, Kang JK, Cho JH, Yu S, Shin HD, Park BL, Cho SW

  • KMID: 782935
  • Korean J Gastroenterol.
  • 2007 Nov;50(5):313-318.
BACKGROUND/AIMS: Infection with hepatitis B virus (HBV) may result in various conditions. Natural course of HBV infection is influenced by various host immune factors and cytokines play a crucial...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Successful Treatment of Protein-Losing Enteropathy Induced by Intestinal Lymphangiectasia in a Liver Cirrhosis Patient with Octreotide: A Case Report

Lee HL, Han DS, Kim JB, Jeon YC, Sohn JH, Hahm JS

A 47-yr-old man with hepatitis B virus associated liver cirrhosis was admitted to our hospital with diarrhea and generalized edema and diagnosed as protein-losing enteropathy due to intestinal lymphangiectasia by...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr